Metabolomic analysis of simvastatin and fenofibrate intervention in high-lipid diet-induced hyperlipidemia rats

被引:0
作者
Qiu-yu Xu
Yin-hui Liu
Qi Zhang
Bo Ma
Zhen-dong Yang
Lei Liu
Di Yao
Guang-bo Cui
Jing-jing Sun
Zi-mei Wu
机构
[1] School of Pharmaceutical Sciences,
[2] Nanjing Tech University,undefined
[3] School of Pharmacy,undefined
[4] FMHS,undefined
[5] The University of Auckland,undefined
来源
Acta Pharmacologica Sinica | 2014年 / 35卷
关键词
simvastatin; fenofibrate; hyperlipidemia; metabolomics; biomarker; creatinine; LDL cholesterol; GC-MS;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1265 / 1273
页数:8
相关论文
共 163 条
  • [1] Jain KS(2007)The biology and chemistry of hyperlipidemia Bioorg Med Chem 15 4674-99
  • [2] Kathiravan MK(1998)Current and future treatment of hyperlipidemia: the role of statins Am J Cardiol 82 3J-10J
  • [3] Somani RS(2004)The role of fibrates in managing hyperlipidemia: mechanisms of action and clinical efficacy Curr Atheroscler Reports 6 148-57
  • [4] Shishoo CJ(1998)Mechanism of action of fibrates on lipid and lipoprotein metabolism Circulation 98 2088-93
  • [5] Farnier M(2008)Metabolomics: a global biochemical approach to drug response and disease Annu Rev Pharmacol Toxicol 48 653-83
  • [6] Davignon J(2008)Standardizing GC-MS metabolomics J Chromatogr B Analyt Technol Biomed Life Sci 871 191-201
  • [7] Fazio S(2011)Semi-automated non-target processing in GC x GC-MS metabolomics analysis: applicability for biomedical studies Metabolomics 7 1-14
  • [8] Linton MF(2012)Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases Anal Bioanal Chem 403 203-13
  • [9] Staels B(2011)Aberrant lipid metabolism in hepatocellular carcinoma revealed by plasma metabolomics and lipid profiling Cancer Res 71 6590-600
  • [10] Dallongeville J(2008)Metabolomics reveals that hepatic stearoyl-CoA desaturase 1 downregulation exacerbates inflammation and acute colitis Cell Metab 7 135-47